Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Raif Tawakol Added: 3 years ago
Many patients on statin therapy understandably develop a false sense of security. They enjoy a lowered level of low-desity lipoprotein (LDL) and a risk reduction of some 35%. However, two out of three patients develop a myocardial infarction (MI) while on a statin therapy. Statins often do not increase HDL levels to any substantial degree (except for Rosuvastatin, which increases high-density… View more
Author(s): Derek V Exner Added: 3 years ago
Why Do We Need Risk Stratification Tools? Sudden death accounts for between 300,000 and 500,000 deaths each year in North America.1 Patients with a history of myocardial infarction (MI) have a four-fold higher risk of sudden death than those without such a history. Most sudden deaths in ambulatory populations result from life-threatening ventricular arrhythmias that lead to a cardiac arrest.2… View more
Author(s): Paul M Ridker Added: 2 years ago
Dr Paul Ridker (Brigham and Women’s Hospital, Boston, US) outlines the findings from a secondary analysis of the CANTOS trial, originally presented at ACC.22 (NCT01327846). CANTOS was a large multinational clinical trial that showed targeting inflammation with canakinumab significantly lowered major cardiovascular events. This secondary analysis was designed to evaluate the influence of lipids… View more
Author(s): John JV McMurray , Mirvat Alasnag , Purvi Parwani , et al Added: 1 year ago
What's hot at European Society of Cardiology (ESC) Congress 22? Stay tuned and browse our curated coverage of the latest data in cardiology. For a concise line up of the most awaited trials joinProf Nicolas Van MieghemandDr Joost Daemen and their regular View From the Thoraxcenter series. For a deeper dive into key clinical trial data and applicability, host, Dr Harriette Van Spall… View more
Foreword

Article

Author(s): Donald E Cutlip Added: 3 years ago
The editorial board and staff are pleased to present the latest issue of US Cardiology Review. The reviews cover important topics in each of five sections of the journal and have been selected based on relevance to daily practice of the general cardiologist and advanced internist. The issue leads off with a review in the Risk Prevention section by Drs. Steven Edelman and Stephen Ku on… View more
Job title: Professor and Senior Consultant
Prof Carolyn Lam is a Senior Consultant at the Department of Cardiology and Director of Women's Heart Health at the National Heart Centre Singapore, having pioneered the first Women’s Heart Clinic in Singapore. Prof Lam is a world-renowned specialist in heart failure (particularly heart failure with preserved ejection fraction [HFpEF]). Her work in the PARAGON-HF and EMPEROR-Preserved trials led… View more
Author(s): Steven B Feinstein Added: 3 years ago
Carotid contrast ultrasound (CU) can be a useful clinical tool for diagnosing surrogate markers of atherosclerosis and identifying the presence of subclinical cardiovascular disease. Although ultrasound contrast agents are currently approved for use in enhancing echocardiograms (ECGs) only, with appropriate Institutional Review Board (IRB) approvals these contrast agents can also be used to… View more
Author(s): Augustus O Grant Added: 3 years ago
It is said that beauty is in the eye of the beholder, and the picture of the American healthcare environment is a prime example. To many Americans, our healthcare system is the most technologically advanced in the world, capable of near-miraculous achievements and perpetual progress. To others, it is a hodgepodge of frustrating bureaucratic systems that lack accountability, impede access to… View more